Matthew S. Francis

Prof. Matthew S. Francis

orcid

Research Focus & Metrics

Academic Career Length

31Years (1996-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
18 January 2007 in The EMBO Journal
Verified
Journal Article
Open access
PDF file
COChristian Ottmann
Christian Ottmann
LYLubna Yasmin
Lubna Yasmin
MWMichael Weyand
Michael Weyand
JVJeffrey L Veesenmeyer
Jeffrey L Veesenmeyer
MDMaureen H Diaz
Maureen H Diaz
BHBengt Hallberg
Bengt Hallberg
14‐3‐3 proteins are phosphoserine/phosphothreonine‐recognizing adapter proteins that regulate the activity of a vast array of targets. There are also examples of 14‐3‐3 proteins binding their targets via unphosphorylated motifs. Here we present a structural and biological investigation of the phosphorylation‐independent interaction between 14‐3‐3 and exoenzyme S (ExoS), an ADP‐ribosyltransferase toxin of Pseudomonas aeruginosa . ExoS binds to 14‐3‐3 in a novel binding mode mostly relying on hydrophobic contacts. The 1.5 Å crystal structure is supported by cytotoxicity analysis, which reveals that substitution of the corresponding hydrophobic residues significantly weakens the ability of ExoS to modify the endogenous targets RAS/RAP1 and to induce cell death. Furthermore, mutation of key residues within the ExoS binding site for 14‐3‐3 impairs virulence in a mouse pneumonia model. In conclusion, we show that ExoS binds 14‐3‐3 in a novel reversed orientation that is primarily dependent on hydrophobic residues. This interaction is phosphorylation independent and is required for the function of ExoS.


1 April 2002 in Current Opinion in Microbiology
Verified
Journal Article
Closed access
MFMatthew S. Francis
Matthew S. Francis

1 November 2001 in Molecular Microbiology
Verified
Journal Article
Open access
PDF file
MFMatthew S. Francis
Matthew S. Francis
SLScott A. Lloyd
Scott A. Lloyd
HWHans Wolf‐Watz
Hans Wolf‐Watz
The enteropathogen Yersinia pseudotuberculosis is a model system used to study the molecular mechanisms by which Gram‐negative pathogens secrete and subsequently translocate antihost effector proteins into target eukaryotic cells by a common type III secretion system (TTSS). In this process, YopD (Yersiniaouter protein D) is essential to establish regulatory control of Yop synthesis and the ensuing translocation process. YopD function depends upon the non‐secreted TTSS chaperone LcrH (low‐calcium response H), which is required for presecretory stabilization of YopD. However, as a new role for TTSS chaperones in virulence gene regulation has been proposed recently, we undertook a detailed analysis of LcrH. A lcrH null mutant constitutively produced Yops, even when this strain was engineered to produce wild‐type levels of YopD. Furthermore, the YopD–LcrH interaction was necessary to regain the negative regulation of virulence associated genes yops). This finding was used to investigate the biological significance of several LcrH mutants with varied YopD binding potential. Mutated LcrH alleles were introduced in trans into a lcrH null mutant to assess their impact on yop regulation and the subsequent translocation of YopE, a Rho‐GTPase activating protein, across the plasma membrane of eukaryotic cells. Two mutants, LcrHK20E, E30G, I31V, M99V, D136G and LcrHE30G lost all regulatory control, even though YopD binding and secretion and the subsequent translocation of YopE was indistinguishable from wild type. Moreover, these regulatory deficient mutants showed a reduced ability to bind YscY in the two‐hybrid assay. Collectively, these findings confirm that LcrH plays an active role in yop regulation that might be mediated via an interaction with the Ysc secretion apparatus. This chaperone–substrate interaction presents an innovative means to establish a regulatory hierarchy in Yersinia infections. It also raises the question as to whether or not LcrH is a true chaperone involved in stabilization and secretion of YopD or a regulatory protein responsible for co‐ordinating synthesis of Yersinia virulence determinants. We suggest that LcrH can exhibit both of these activities.

27 September 2002 in European Journal of Biochemistry
Verified
Journal Article
Open access
PDF file
MHMaria L. Henriksson
Maria L. Henriksson
MFMatthew S. Francis
Matthew S. Francis
APAlex Peden
Alex Peden
MAMargareta Aili
Margareta Aili
KSKristina Anna Ingrid Stefansson
Kristina Anna Ingrid Stefansson
BHBengt Hallberg
Bengt Hallberg
14‐3‐3 proteins play an important role in a multitude of signalling pathways. The interactions between 14‐3‐3 and other signalling proteins, such as Raf and KSR (kinase suppressor of Ras), occur in a phospho‐specific manner. Recently, a phosphorylation‐independent interaction has been reported to occur between 14‐3‐3 and several proteins, for example 5‐phosphatase, p75NTR‐associated cell death executor (NADE) and the bacterial toxin Exoenzyme S (ExoS), an ADP‐ribosyltransferase from Pseudomonas aeruginosa. In this study we have identified the amino acid residues on ExoS, which are responsible for its specific interaction with 14‐3‐3. Furthermore, we show that a peptide derived from ExoS, containing the 14‐3‐3 interaction site, effectively competes out the interaction between ExoS and 14‐3‐3. In addition, competition with this peptide blocks ExoS modification of Ras in our Ras modification assay. We show that the ExoS protein interacts with all isoforms of the 14‐3‐3 family tested. Moreover, in vivo an ExoS protein lacking the 14‐3‐3 binding site has a reduced capacity to ADP ribosylate cytoplasmic proteins, e.g. Ras, and shows a reduced capacity to change the morphology of infected cells.

27 February 2015 in mBio
Verified
Journal Article
Open access
PDF file
EZErin E Zwack
Erin E Zwack
ASAnnelise G Snyder
Annelise G Snyder
MWMeghan A Wynosky-Dolfi
Meghan A Wynosky-Dolfi
GRGordon Ruthel
Gordon Ruthel
NPNaomi H Philip
Naomi H Philip
IBIgor E. Brodsky
Igor E. Brodsky
Type III secretion systems (T3SS) translocate effector proteins into target cells in order to disrupt or modulate host cell signaling pathways and establish replicative niches. However, recognition of T3SS activity by cytosolic pattern recognition receptors (PRRs) of the nucleotide-binding domain leucine rich repeat (NLR) family, either through detection of translocated products or membrane disruption, induces assembly of multiprotein complexes known as inflammasomes. Macrophages infected with Yersinia pseudotuberculosis strains lacking all known effectors or lacking the translocation regulator YopK induce rapid activation of both the canonical NLRP3 and noncanonical caspase-11 inflammasomes. While this inflammasome activation requires a functional T3SS, the precise signal that triggers inflammasome activation in response to Yersinia T3SS activity remains unclear. Effectorless strains of Yersinia as well as Δ yopK strains translocate elevated levels of T3SS substrates into infected cells. To dissect the contribution of pore formation and translocation to inflammasome activation, we took advantage of variants of YopD and LcrH that separate these functions of the T3SS. Notably, YopD variants that abrogated translocation but not pore-forming activity failed to induce inflammasome activation. Furthermore, analysis of individual infected cells revealed that inflammasome activation at the single-cell level correlated with translocated levels of YopB and YopD themselves. Intriguingly, LcrH mutants that are fully competent for effector translocation but produce and translocate lower levels of YopB and YopD also fail to trigger inflammasome activation. Our findings therefore suggest that hypertranslocation of YopD and YopB is linked to inflammasome activation in response to the Yersinia T3SS. IMPORTANCE The innate immune response is critical to effective clearance of pathogens. Recognition of conserved virulence structures and activities by innate immune receptors such as NLRs constitute one of the first steps in mounting the innate immune response. However, pathogens such as Yersinia actively evade or subvert components of host defense, such as inflammasomes. The T3SS-secreted protein YopK is an essential virulence factor that limits translocation of other Yops, thereby limiting T3SS-induced inflammasome activation. However, what triggers inflammasome activation in cells infected by YopK-deficient Yersinia is not clear. Our findings indicate that hypertranslocation of pore complex proteins promotes inflammasome activation and that YopK prevents inflammasome activation by the T3SS by limiting translocation of YopD and YopB themselves.